Get started
Author

Harshini Kumaresan

Observed name: H Kumaresan
ORCID: 0009-0001-7104-6343
Observed ORCID: 0009-0001-7104-6343
OpenAlex ID: A5019743373
Recombinant adjuvant zoster vaccine-associated acute mucocutaneous toxicity
2025 · N Choma, H Kumaresan, et al. · Scandinavian Journal of Rheumatology · 1
Skin and Soft Tissue Infections Clinical Pathway Concordance in Pediatric Emergency and Urgent Care Sites
2026 · Harshini Kumaresan, Amanda Nedved, et al. · American Journal of Infection Control
A56-06 Organ Specific Differences in DNA Oxidative Injury Between Females and Males in Response to Resuscitation With Blood and Protection With Phospholipid Nanoparticles (VBI-1)
2026 · H Kumaresan, P Shallie, et al. · American Journal of Respiratory and Critical Care Medicine
Phospholipid Nanoparticle Resuscitation Preserves Neuronal Integrity and Cognitive Recovery Without Exacerbating Neuroinflammation Following Hemorrhagic Shock-Induced Clinical Death
2026 · Philemon Shallie, Nathan Carpenter, et al. · Biomedicines
P-407. Adherence to Clinical Pathways in the Management of Pediatric Skin and Soft Tissue Infections
2026 · Harshini Kumaresan, Amanda Nedved, et al. · Open Forum Infectious Diseases
S1989 Clinical Outcomes Associated With Detection of Non-Clostridioides difficile Enteric Pathogens During IBD Flares
2025 · Zaid Al Momani, Osama Asad, et al. · The American Journal of Gastroenterology
Functional Tricuspid Stenosis Secondary to Bulky Infective Endocarditis: an Uncommon Presentation
2025 · Harshini Kumaresan, Talal Asif · Journal of the American College of Cardiology
PDF
Addressing Physician Shortages by Broadening of Licensure Pathways for International Medical Graduates.
2025 · Fariha Shafi, Sandeep Yanamala, et al. · PubMed
Works count: 8
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type